TickerFacts.

NeoGenomics Inc (NEO): Capital Expenditures

Annual figures by period end, from SEC filings.

$27.01M
Year ended 2025-12-31
$29.40M
Trailing 12 months to 2026-06-30
-4.4%
3-year compound annual growth
-1.5%
5-year compound annual growth
+28.4%
10-year compound annual growth
$64.14M2010-12-31: $916.0K2011-12-31: $897.0K2012-12-31: $2.62M2013-12-31: $2.01M2014-12-31: $3.77M2015-12-31: $2.21M2016-12-31: $7.54M2017-12-31: $13.69M2018-12-31: $14.31M2019-12-31: $20.03M2020-12-31: $29.10M2021-12-31: $64.14M2022-12-31: $30.89M2023-12-31: $28.75M2024-12-31: $41.06M2025-12-31: $27.01M$27.01M
2010-12-31 Capital Expenditures (USD) 2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-31$27.01M-34.2%2026-02-17, From 2025-01-01
2024-12-31$41.06M+42.8%2026-02-17, From 2024-01-01
2023-12-31$28.75M-6.9%2026-02-17, From 2023-01-01
2022-12-31$30.89M-51.8%2025-02-18, From 2022-01-01
2021-12-31$64.14M+120.4%2024-02-20, From 2021-01-01
2020-12-31$29.10M+45.3%2023-02-24, From 2020-01-01
2019-12-31$20.03M+40.0%2022-02-25, From 2019-01-01
2018-12-31$14.31M+4.5%2021-02-25, From 2018-01-01
2017-12-31$13.69M+81.7%2020-02-28, From 2017-01-01
2016-12-31$7.54M+240.2%2019-02-26, From 2016-01-01
2015-12-31$2.21M-41.3%2018-03-13, From 2015-01-01
2014-12-31$3.77M+87.6%2017-03-14, From 2014-01-01
2013-12-31$2.01M-23.1%2016-04-18, From 2013-01-01
2012-12-31$2.62M+191.5%2015-03-03, From 2012-01-01
2011-12-31$897.0K-2.1%2014-02-24, From 2011-01-01
2010-12-31$916.0Kn/a2012-03-12, From 2010-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Services-Testing Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
NeoGenomics Inc (NEO)2025-12-31$27.01M-34.2%
UL Solutions Inc. (ULS)2025-12-31$197.00M-16.9%
Hypha Labs, Inc. (FUNI)2025-09-30$33.0K+19.2%

Compare NEO, ULS, FUNI side by side · Screen every company in Services-Testing Laboratories ↗